BWAY vs. INMD, IRMD, KMTS, EMBC, BBNX, TNDM, AXGN, SIBN, BVS, and ZIMV
Should you be buying Brainsway stock or one of its competitors? The main competitors of Brainsway include InMode (INMD), iRadimed (IRMD), Kestra Medical Technologies (KMTS), Embecta (EMBC), Beta Bionics (BBNX), Tandem Diabetes Care (TNDM), AxoGen (AXGN), SiBone (SIBN), Bioventus (BVS), and ZimVie (ZIMV). These companies are all part of the "medical equipment" industry.
Brainsway vs. Its Competitors
InMode (NASDAQ:INMD) and Brainsway (NASDAQ:BWAY) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.
InMode has higher revenue and earnings than Brainsway. InMode is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.
InMode has a beta of 1.93, indicating that its stock price is 93% more volatile than the S&P 500. Comparatively, Brainsway has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500.
InMode currently has a consensus target price of $18.04, indicating a potential upside of 18.77%. Brainsway has a consensus target price of $18.00, indicating a potential upside of 17.96%. Given InMode's higher probable upside, equities analysts clearly believe InMode is more favorable than Brainsway.
InMode has a net margin of 44.50% compared to Brainsway's net margin of 11.60%. InMode's return on equity of 18.38% beat Brainsway's return on equity.
In the previous week, InMode and InMode both had 8 articles in the media. InMode's average media sentiment score of 1.76 beat Brainsway's score of 0.30 indicating that InMode is being referred to more favorably in the media.
68.0% of InMode shares are owned by institutional investors. Comparatively, 30.1% of Brainsway shares are owned by institutional investors. 6.9% of InMode shares are owned by insiders. Comparatively, 19.0% of Brainsway shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Summary
InMode beats Brainsway on 10 of the 15 factors compared between the two stocks.
Get Brainsway News Delivered to You Automatically
Sign up to receive the latest news and ratings for BWAY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding BWAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Brainsway Competitors List
Related Companies and Tools
This page (NASDAQ:BWAY) was last updated on 8/28/2025 by MarketBeat.com Staff